As the amount of media coverage devoted to psychedelic-assisted therapy grows, researchers and practitioners must now content with the expectations of study participants and patients, many of whom are desperate for help. Alongside questions of hype an expectation, many participants, patients, and practitioners themselves are underinformed about their risks. Join us for a panel devoted to exploring the challenges of managing these factors during the research and therapy process.